The CBD Vault Exploring China Distribution and JV Opportunities
The CBD Vault, a subsidiary of CBD Life Sciences Inc. (CBDL), is exploring distribution and joint venture opportunities in China following new CBD regulations effective September 1st. The USDA memo indicates that CBD is now integrated into China's 'precursor chemicals management system', allowing for nationwide production and marketing with proper applications. This expands beyond previous limitations to Yunnan and Heilongjiang provinces.
Lisa Nelson, President & CEO of CBDL, sees this as an opportune time to strike deals in China's CBD sector. The company is actively working with wholesalers, distributors, retailers, and merchant banks to locate new business opportunities. The CBD Vault offers a full line of cannabidiol-based and organic products, including Delta 8 & 10 Gummy's, tinctures, pain creams, and pet products, available on their website www.thecbdvault.com.
The CBD Vault, una filiale di CBD Life Sciences Inc. (CBDL), sta esplorando opportunità di distribuzione e joint venture in Cina dopo le nuove normative sul CBD che entreranno in vigore il 1° settembre. Il memo del USDA indica che il CBD è ora integrato nel 'sistema di gestione dei precursori chimici' in Cina, consentendo la produzione e la commercializzazione a livello nazionale con le giuste autorizzazioni. Questo amplia le limitazioni precedenti alle province di Yunnan e Heilongjiang.
Lisa Nelson, Presidente e CEO di CBDL, considera questo un momento opportuno per stipulare accordi nel settore del CBD in Cina. L'azienda sta lavorando attivamente con grossisti, distributori, rivenditori e banche merchant per individuare nuove opportunità di business. The CBD Vault offre una linea completa di prodotti a base di cannabinoidi e biologici, tra cui gummy Delta 8 e 10, tinture, creme per il dolore e prodotti per animali, disponibili sul loro sito web www.thecbdvault.com.
The CBD Vault, una subsidiaria de CBD Life Sciences Inc. (CBDL), está explorando oportunidades de distribución y asociación en China tras las nuevas regulaciones de CBD que entrarán en vigor el 1 de septiembre. El memo del USDA indica que el CBD ahora está integrado en el 'sistema de gestión de productos químicos precursores' de China, lo que permite la producción y comercialización a nivel nacional con las debidas solicitudes. Esto se expande más allá de las limitaciones anteriores a las provincias de Yunnan y Heilongjiang.
Lisa Nelson, Presidenta y CEO de CBDL, ve esto como un momento oportuno para establecer acuerdos en el sector del CBD en China. La compañía está trabajando activamente con mayoristas, distribuidores, minoristas y bancos comerciales para encontrar nuevas oportunidades de negocio. The CBD Vault ofrece una línea completa de productos a base de cannabidiol y orgánicos, incluyendo gomitas Delta 8 y 10, tinturas, cremas para el dolor y productos para mascotas, disponibles en su sitio web www.thecbdvault.com.
The CBD Vault는 CBD Life Sciences Inc. (CBDL)의 자회사로서 9월 1일부터 시행되는 새로운 CBD 규제에 따라 중국에서 유통 및 합작 투자 기회를 탐색하고 있습니다. USDA 메모에 따르면, CBD는 이제 중국의 '전구체 화학 물질 관리 시스템'에 통합되어 적절한 신청을 통해 전국적인 생산과 마케팅이 가능해졌습니다. 이는 이전의 윈난 및 헤이룽장 성의 제한을 넘어섭니다.
Lisa Nelson, CBDL의 회장 겸 CEO는 이를 중국 CBD 분야에서 거래를 성사시킬 수 있는 적기라고 보고 있습니다. 회사는 도매업체, 유통업체, 소매업체 및 상업 은행과 적극적으로 협력하여 새로운 비즈니스 기회를 찾고 있습니다. The CBD Vault는 Delta 8 및 10 젤리, 팅크, 통증 크림 및 반려동물 제품을 포함한 전체 캐나비디올 기반 및 유기농 제품 라인을 www.thecbdvault.com 웹사이트에서 제공합니다.
The CBD Vault, une filiale de CBD Life Sciences Inc. (CBDL), explore des opportunités de distribution et de coentreprise en Chine suite à de nouvelles réglementations sur le CBD qui entreront en vigueur le 1er septembre. Le mémo du USDA indique que le CBD est désormais intégré dans le 'système de gestion des produits chimiques précurseurs' de la Chine, ce qui permet une production et une commercialisation à l'échelle nationale avec les bonnes démarches. Cela va au-delà des limitations précédentes des provinces du Yunnan et du Heilongjiang.
Lisa Nelson, Présidente et CEO de CBDL, considère cela comme un moment opportun pour conclure des accords dans le secteur du CBD en Chine. L'entreprise travaille activement avec des grossistes, distributeurs, détaillants et banques de commerce pour identifier de nouvelles opportunités commerciales. The CBD Vault propose une gamme complète de produits à base de cannabidiol et biologiques, y compris des gommes Delta 8 et 10, des teintures, des crèmes contre la douleur et des produits pour animaux de compagnie, disponibles sur leur site web www.thecbdvault.com.
The CBD Vault, eine Tochtergesellschaft von CBD Life Sciences Inc. (CBDL), erkundet Vertrieb und Joint-Venture-Möglichkeiten in China nach den neuen CBD-Vorschriften, die am 1. September in Kraft treten. Das USDA-Memo zeigt, dass CBD jetzt in Chinas 'Verwaltungssystem für Vorläuferchemikalien' integriert ist, was eine landesweite Produktion und Vermarktung mit den richtigen Anträgen ermöglicht. Dies erweitert sich über die bisherigen Beschränkungen auf die Provinzen Yunnan und Heilongjiang hinaus.
Lisa Nelson, Präsidentin und CEO von CBDL, sieht dies als günstige Gelegenheit, um Geschäfte im CBD-Sektor Chinas abzuschließen. Das Unternehmen arbeitet aktiv mit Großhändlern, Distributoren, Einzelhändlern und Investmentbanken, um neue Geschäftsmöglichkeiten zu finden. The CBD Vault bietet eine komplette Linie von cannabinoidbasierten und organischen Produkten an, darunter Delta 8 & 10 Gummis, Tinkturen, Schmerzcremes und Produkte für Haustiere, die auf ihrer Website www.thecbdvault.com erhältlich sind.
- New Chinese regulations allow for nationwide CBD production and marketing, expanding market opportunities
- CBDL actively pursuing distribution and joint venture opportunities in China
- Potential for increased revenues through international expansion
- Strict regulations on CBD production, operation, purchase, transportation, import, and export in China
- Competition may increase as more companies enter the Chinese CBD market
SCOTTSDALE, AZ / ACCESSWIRE / August 20, 2024 / The landscape of the CBD industry in China is set to undergo a transformative shift with the introduction of new regulations effective September 1st. According to a recent memo from the USDA, CBD is among seven substances now integrated into China's "precursor chemicals management system." This change, based on an official Chinese government announcement, marks a significant development for the industry.
Under these new guidelines, CBD's production, operation, purchase, transportation, import, and export activities will be governed by the stringent regulations applicable to non-pharmaceutical precursor chemicals. Importantly, CBD now holds a defined classification within China's internal "harmonized tariff system," offering clarity and structure for the market.
The USDA memo highlights a critical advancement: with the proper applications filed in accordance with People's Republic of China (PRC) regulations, CBD can now be legally produced and marketed nationwide. This expansion moves beyond the previous limitations, which restricted production to the Yunnan and Heilongjiang provinces.
US alerts hemp sector to new Chinese CBD regulations (mjbizdaily.com)
Lisa Nelson, President & CEO of CBDL, expressed major interest about these new CBD policies stating, "Now is the best time to strike deals in the CBD sector overseas in China. We are already working with wholesalers, distributors, retail and working with merchant banks to locate new businesses for the CBD sector. Engaging in these conversations are early as possible will give us a head start into closing huge deals overseas that can lift our revenues much higher and become a top company in the CBD space."
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based & organic products including, Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, Roll-on's, Salve, Full Pet Line, Pre-Rolls, Full Line of Spa Products, Sleep & Anxiety Edibles. The CBD Vault's products can be viewed and purchased on the Company's website www.thecbdvault.com.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What are the new CBD regulations in China effective September 1st, 2024?
How is CBDL (CBD Life Sciences Inc.) responding to the new Chinese CBD regulations?
What products does The CBD Vault, a subsidiary of CBDL, offer?
How might the new Chinese CBD regulations impact CBDL's revenue?
